title: A β-lactamase inhibitor revival provides new hope for old antibiotics.
authors.forename: Ken
authors.initials: K
authors.lastname: Garber
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D053961:Azabicyclo Compounds / Q000494:pharmacology / Q000627:therapeutic use; D002442:Ceftazidime / Q000494:pharmacology / Q000627:therapeutic use; D017277:Drug Approval; D004338:Drug Combinations; D024881:Drug Resistance, Bacterial / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D014481:United States; D065093:beta-Lactamase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D053961:Azabicyclo Compounds; D004338:Drug Combinations; C000595613:avibactam, ceftazidime drug combination; D065093:beta-Lactamase Inhibitors; D002442:Ceftazidime